Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty

Badulescu, Oana Viola; Tudor, Razvan; Friedl, Wilhelm; Scripcaru, Andrei; Sirbu, Paul Dan

Oana Viola Badulescu, Razvan Tudor, Wilhelm Friedl, Andrei Scripcaru, Paul Dan Sirbu

Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty

Abstract:

Type A haemophilia is a hereditary coagulopathy caused by coagulation factor VIII deficiency as part of the rare, life-threatening and at-risk group of diseases that has been attributed over time a life-saving substitution treatment providing to patients diagnosed with this pathology a hope for life and quality of life similar to that of healthy population. However, substitution treatment is very expensive so that nowadays globally most patients cannot benefit from proper healthcare. The quality of healthcare is dependent on the socio-economic level of each country, being decisively influenced by the power of the National Hemophilia Organizations to generate solidarity and support of decision-makers of each country. One of the bleeding manifestations specific to haemophilia is haemarthrosis. Each haemorrhagic episode causes locally a disorder that predisposes to relapse, with the onset of the main chronic complication of this condition, haemophilic arthropathy. It has a slow evolution throughout the life of the patient and generates in time severe sequelae (ankyloses) that require total arthroplasty. Effective hemostasis is the essential element for performing this type of orthopaedic surgery, due to bleeding risk that is of vital nature, in this category of patients. In this sense, this study aims to underline the efficacy of Moroctocog alfa in the management of haemostasis in haemophiliac patients with total endoprosthesis indication, aimed to reduce joint pain and improve locomotor function.

Keywords:
haemophilia; Moroctocog alfa; haemarthrosis; total arthroplasty

Issue: 2018, Volume 69, Issue 6

Pages: 1541-1543

Publication date: 2018/7/15

https://doi.org/10.37358/RC.18.6.6364

Download Pdf Article

This article is published under the Creative Commons Attribution 4.0 International License

Citation Styles

Cite this article as:
BADULESCU, O.V., TUDOR, R., FRIEDL, W., SCRIPCARU, A., SIRBU, P.D., Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty, Rev. Chim., 69(6), 2018, 1541-1543.

Vancouver
Badulescu OV, Tudor R, Friedl W, Scripcaru A, Sirbu PD. Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty. Rev. Chim.[internet]. 2018 Jun;69(6):1541-1543. Available from: https://doi.org/10.37358/RC.18.6.6364

APA 6th edition
Badulescu, O.V., Tudor, R., Friedl, W., Scripcaru, A. & Sirbu, P.D. (2018). Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty. Revista de Chimie, 69(6), 1541-1543. https://doi.org/10.37358/RC.18.6.6364

Harvard
Badulescu, O.V., Tudor, R., Friedl, W., Scripcaru, A., Sirbu, P.D. (2018). 'Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty', Revista de Chimie, 69(6), pp. 1541-1543. https://doi.org/10.37358/RC.18.6.6364

IEEE
O.V. Badulescu, R. Tudor, W. Friedl, A. Scripcaru, P.D. Sirbu, "Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty". Revista de Chimie, vol. 69, no. 6, pp. 1541-1543, 2018. [online]. https://doi.org/10.37358/RC.18.6.6364

Text
Oana Viola Badulescu, Razvan Tudor, Wilhelm Friedl, Andrei Scripcaru, Paul Dan Sirbu,
Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty,
Revista de Chimie,
Volume 69, Issue 6,
2018,
Pages 1541-1543,
ISSN 2668-8212,
https://doi.org/10.37358/RC.18.6.6364.
(https://revistadechimie.ro/Articles.asp?ID=6364)
Keywords: haemophilia; Moroctocog alfa; haemarthrosis; total arthroplasty

RIS
TY - JOUR
T1 - Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty
A1 - Badulescu, Oana Viola
A2 - Tudor, Razvan
A3 - Friedl, Wilhelm
A4 - Scripcaru, Andrei
A5 - Sirbu, Paul Dan
JF - Revista de Chimie
JO - Rev. Chim.
PB - Revista de Chimie SRL
SN - 2668-8212
Y1 - 2018
VL - 69
IS - 6
SP - 1541
EP - 1543
UR - https://doi.org/10.37358/RC.18.6.6364
KW - haemophilia
KW - Moroctocog alfa
KW - haemarthrosis
KW - total arthroplasty
ER -

BibTex
@article{RevCh2018P1541,
author = {Badulescu Oana Viola and Tudor Razvan and Friedl Wilhelm and Scripcaru Andrei and Sirbu Paul Dan},
title = {Moroctocog Alfa Efficacy in Hemostasis Management in A Type Hemophilia Patients with Elective Arthroplasty},
journal = {Revista de Chimie},
volume = {69},
number = {6},
pages = {1541-1543},
year = {2018},
issn = {2668-8212},
doi = {https://doi.org/10.37358/RC.18.6.6364},
url = {https://revistadechimie.ro/Articles.asp?ID=6364}
}

<<<< back

PUBLISHING SECTION

Author Guidelines

* Paper Drafting

* Paper Template

* Ethical Statement

* Paper Submission

Ghidul Autorului (ro)

Open Access & Archiving Policy

Search Authors

LATEST NEWS
	NUMAR OMAGIAL PETRU PONI.. detalii
	Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
	English-Romanian Dictionary for Mechanical Engineering (download pdf)